Login / Signup

Head-to-head comparison of aggressive conventional therapy and three biological treatments and comparison of two de-escalation strategies in patients who respond to treatment: study protocol for a multicenter, randomized, open-label, blinded-assessor, phase 4 study.

Daniel GlinatsiMarte S HeibergAnna RudinDan NordströmEspen A HaavardsholmBjorn GudbjornssonMikkel ØstergaardTill UhligGerdur GrondalKim Hørslev-PetersenRonald van VollenhovenMerete L Hetland
Published in: Trials (2017)
NCT01491815 and NCT02466581 . Registered on 8 December 2011 and May 2015, respectively. EudraCT: 2011-004720-35.
Keyphrases
  • open label
  • phase iii
  • phase ii
  • double blind
  • placebo controlled
  • study protocol
  • clinical trial
  • phase ii study
  • optic nerve
  • randomized controlled trial
  • cross sectional
  • squamous cell carcinoma
  • rectal cancer